Literature DB >> 25921540

Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79 Di- and tri-methylation on target genes and transformation potential.

Aravinda Kuntimaddi1, Nicholas J Achille2, Jeremy Thorpe3, Alyson A Lokken2, Ritambhara Singh3, Charles S Hemenway4, Mazhar Adli3, Nancy J Zeleznik-Le5, John H Bushweller6.   

Abstract

The MLL gene is a common target of chromosomal translocations found in human leukemia. MLL-fusion leukemia has a consistently poor outcome. One of the most common translocation partners is AF9 (MLLT3). MLL-AF9 recruits DOT1L, a histone 3 lysine 79 methyltransferase (H3K79me1/me2/me3), leading to aberrant gene transcription. We show that DOT1L has three AF9 binding sites and present the nuclear magnetic resonance (NMR) solution structure of a DOT1L-AF9 complex. We generate structure-guided point mutations and find that they have graded effects on recruitment of DOT1L to MLL-AF9. Chromatin immunoprecipitation sequencing (ChIP-seq) analyses of H3K79me2 and H3K79me3 show that graded reduction of the DOT1L interaction with MLL-AF9 results in differential loss of H3K79me2 and me3 at MLL-AF9 target genes. Furthermore, the degree of DOT1L recruitment is linked to the level of MLL-AF9 hematopoietic transformation.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25921540      PMCID: PMC4426023          DOI: 10.1016/j.celrep.2015.04.004

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  36 in total

1.  Whole-genome chromatin profiling from limited numbers of cells using nano-ChIP-seq.

Authors:  Mazhar Adli; Bradley E Bernstein
Journal:  Nat Protoc       Date:  2011-09-29       Impact factor: 13.491

Review 2.  The diverse functions of Dot1 and H3K79 methylation.

Authors:  Anh Tram Nguyen; Yi Zhang
Journal:  Genes Dev       Date:  2011-07-01       Impact factor: 11.361

Review 3.  A million peptide motifs for the molecular biologist.

Authors:  Peter Tompa; Norman E Davey; Toby J Gibson; M Madan Babu
Journal:  Mol Cell       Date:  2014-07-17       Impact factor: 17.970

4.  AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.

Authors:  Aniruddha J Deshpande; Anagha Deshpande; Amit U Sinha; Liying Chen; Jenny Chang; Ali Cihan; Maurizio Fazio; Chun-Wei Chen; Nan Zhu; Richard Koche; Liuda Dzhekieva; Gloria Ibáñez; Stuart Dias; Deepti Banka; Andrei Krivtsov; Minkui Luo; Robert G Roeder; James E Bradner; Kathrin M Bernt; Scott A Armstrong
Journal:  Cancer Cell       Date:  2014-11-20       Impact factor: 31.743

5.  CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.

Authors:  Jiaying Tan; Morgan Jones; Haruhiko Koseki; Manabu Nakayama; Andrew G Muntean; Ivan Maillard; Jay L Hess
Journal:  Cancer Cell       Date:  2011-11-15       Impact factor: 31.743

6.  Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes.

Authors:  Debabrata Biswas; Thomas A Milne; Venkatesha Basrur; Jaehoon Kim; Kojo S J Elenitoba-Johnson; C David Allis; Robert G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-06       Impact factor: 11.205

7.  DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis.

Authors:  Anh Tram Nguyen; Olena Taranova; Jin He; Yi Zhang
Journal:  Blood       Date:  2011-04-26       Impact factor: 22.113

8.  Importance of a specific amino acid pairing for murine MLL leukemias driven by MLLT1/3 or AFF1/4.

Authors:  Alyson A Lokken; Nicholas J Achille; Ming-Jin Chang; Jeffrey J Lin; Aravinda Kuntimaddi; Benjamin I Leach; Bhavna Malik; Jacqueline B Nesbit; Shubin Zhang; John H Bushweller; Nancy J Zeleznik-Le; Charles S Hemenway
Journal:  Leuk Res       Date:  2014-08-24       Impact factor: 3.156

Review 9.  Short linear motifs: ubiquitous and functionally diverse protein interaction modules directing cell regulation.

Authors:  Kim Van Roey; Bora Uyar; Robert J Weatheritt; Holger Dinkel; Markus Seiler; Aidan Budd; Toby J Gibson; Norman E Davey
Journal:  Chem Rev       Date:  2014-06-13       Impact factor: 60.622

10.  Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.

Authors:  Theresa Placke; Katrin Faber; Atsushi Nonami; Sarah L Putwain; Helmut R Salih; Florian H Heidel; Alwin Krämer; David E Root; David A Barbie; Andrei V Krivtsov; Scott A Armstrong; William C Hahn; Brian J Huntly; Stephen M Sykes; Michael D Milsom; Claudia Scholl; Stefan Fröhling
Journal:  Blood       Date:  2014-04-24       Impact factor: 22.113

View more
  50 in total

Review 1.  The upstreams and downstreams of H3K79 methylation by DOT1L.

Authors:  Hanneke Vlaming; Fred van Leeuwen
Journal:  Chromosoma       Date:  2016-01-04       Impact factor: 4.316

Review 2.  Activation and regulation of H2B-Ubiquitin-dependent histone methyltransferases.

Authors:  Evan J Worden; Cynthia Wolberger
Journal:  Curr Opin Struct Biol       Date:  2019-06-21       Impact factor: 6.809

3.  Mechanism of Cross-talk between H2B Ubiquitination and H3 Methylation by Dot1L.

Authors:  Evan J Worden; Niklas A Hoffmann; Chad W Hicks; Cynthia Wolberger
Journal:  Cell       Date:  2019-02-11       Impact factor: 41.582

Review 4.  ENL: structure, function, and roles in hematopoiesis and acute myeloid leukemia.

Authors:  Jianbiao Zhou; Yvonne Ng; Wee-Joo Chng
Journal:  Cell Mol Life Sci       Date:  2018-07-31       Impact factor: 9.261

5.  The BRD3 ET domain recognizes a short peptide motif through a mechanism that is conserved across chromatin remodelers and transcriptional regulators.

Authors:  Dorothy C C Wai; Taylor N Szyszka; Amy E Campbell; Cherry Kwong; Lorna E Wilkinson-White; Ana P G Silva; Jason K K Low; Ann H Kwan; Roland Gamsjaeger; James D Chalmers; Wayne M Patrick; Bin Lu; Christopher R Vakoc; Gerd A Blobel; Joel P Mackay
Journal:  J Biol Chem       Date:  2018-03-22       Impact factor: 5.157

Review 6.  Mixed-Lineage Leukemia Fusions and Chromatin in Leukemia.

Authors:  Andrei V Krivtsov; Takayuki Hoshii; Scott A Armstrong
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

Review 7.  Targeting DOT1L and HOX gene expression in MLL-rearranged leukemia and beyond.

Authors:  Chun-Wei Chen; Scott A Armstrong
Journal:  Exp Hematol       Date:  2015-06-25       Impact factor: 3.084

Review 8.  Drugging Chromatin in Cancer: Recent Advances and Novel Approaches.

Authors:  Sheng F Cai; Chun-Wei Chen; Scott A Armstrong
Journal:  Mol Cell       Date:  2015-11-19       Impact factor: 17.970

9.  Peptidomimetics for Targeting Protein-Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL.

Authors:  Lei Du; Sierrah M Grigsby; Aihong Yao; Yujie Chang; Garrett Johnson; Haiying Sun; Zaneta Nikolovska-Coleska
Journal:  ACS Med Chem Lett       Date:  2018-08-06       Impact factor: 4.345

10.  The histone methyltransferase DOT1L: regulatory functions and a cancer therapy target.

Authors:  Matthew Wong; Patsie Polly; Tao Liu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.